Does Afirma Molecular Testing Reduce Surgery Rates and Improve Management Appropriateness in Bethesda III–IV Thyroid Nodules?

Journal of Traditional and Complementary Medicine · Elsevier

Аннотация

Publication date: September–October 2026 Source: Journal of the American Society of Cytopathology, Volume 15, Issue 5 Author(s): S. Mohsen Hosseini

Читать у издателя →

Похожие статьи